<VariationArchive RecordType="classified" VariationID="30313" VariationName="NM_005902.4(SMAD3):c.313del (p.Ala105fs)" VariationType="Deletion" Accession="VCV000030313" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-11-05" DateCreated="2014-11-17" MostRecentSubmission="2019-04-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39269" VariationID="30313">
      <GeneList>
        <Gene Symbol="SMAD3" FullName="SMAD family member 3" GeneID="4088" HGNC_ID="HGNC:6769" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="67065602" stop="67195169" display_start="67065602" display_stop="67195169" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="67358194" stop="67487532" display_start="67358194" display_stop="67487532" Strand="+" />
          </Location>
          <OMIM>603109</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD3">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_005902.4(SMAD3):c.313del (p.Ala105fs)</Name>
      <CanonicalSPDI>NC_000015.10:67164998:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="67164999" stop="67164999" display_start="67164999" display_stop="67164999" variantLength="1" positionVCF="67164998" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="67457337" stop="67457337" display_start="67457337" display_stop="67457337" variantLength="1" positionVCF="67457336" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>A61fs</ProteinChange>
      <ProteinChange>A105fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.67165001del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.67165001del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.67457339del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.67457339del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011990.1" sequenceAccession="NG_011990" sequenceVersion="1" change="g.104145del">
            <Expression>NG_011990.1:g.104145del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145102.2" sequenceAccession="NM_001145102" sequenceVersion="2" change="c.-3del">
            <Expression>NM_001145102.2:c.-3del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145103.2" sequenceAccession="NM_001145103" sequenceVersion="2" change="c.181del">
            <Expression>NM_001145103.2:c.181del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138575.1" sequenceAccession="NP_001138575" sequenceVersion="1" change="p.Ala61fs">
            <Expression>NP_001138575.1:p.Ala61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005902.4" sequenceAccession="NM_005902" sequenceVersion="4" change="c.313del" MANESelect="true">
            <Expression>NM_005902.4:c.313del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005893.1" sequenceAccession="NP_005893" sequenceVersion="1" change="p.Ala105fs">
            <Expression>NP_005893.1:p.Ala105fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA020072" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603109.0008" DB="OMIM" />
        <XRef Type="rs" ID="587776882" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="effect on translation">
        <XRef ID="0399" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005902.4(SMAD3):c.313del (p.Ala105fs) AND Aneurysm-osteoarthritis syndrome" Accession="RCV000023248" Version="4">
        <ClassifiedConditionList TraitSetID="7467">
          <ClassifiedCondition DB="MedGen" ID="C3151087">Aneurysm-osteoarthritis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005902.4(SMAD3):c.313del (p.Ala105fs) AND not provided" Accession="RCV000767318" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-01-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2014-11-17" MostRecentSubmission="2019-04-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <URL>https://www.biorxiv.org/content/10.1101/310375v1</URL>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22167769</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7467" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16102" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANEURYSMS-OSTEOARTHRITIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LOEYS-DIETZ SYNDROME WITH OSTEOARTHRITIS</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Loeys-Dietz syndrome 3</ElementValue>
                <XRef ID="Loeys-Dietz+syndrome%2C+type+1C/8764" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Loeys-Dietz syndrome, type 1C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aneurysm-osteoarthritis syndrome</ElementValue>
                <XRef ID="MONDO:0013426" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LDS1C</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LDS3</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMAD3</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.</Attribute>
                <XRef ID="NBK1133" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10997" />
                <XRef ID="10997" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301312</ID>
                <ID Source="BookShelf">NBK1133</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="284984" DB="Orphanet" />
              <XRef ID="C3151087" DB="MedGen" />
              <XRef ID="MONDO:0013426" DB="MONDO" />
              <XRef Type="MIM" ID="613795" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49795" SubmissionDate="2014-11-14" DateLastUpdated="2014-11-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603109.0008_LOEYS-DIETZ SYNDROME 3" title="SMAD3, 1-BP DEL, 313G_LOEYS-DIETZ SYNDROME 3" />
        <ClinVarAccession Accession="SCV000044539" DateUpdated="2014-11-17" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with aneurysms-osteoarthritis syndrome (LCS3; 613795), van de Laar et al. (2012) identified a 1-bp deletion at nucleotide 313 of the SMAD3 gene (313delG), resulting in a frameshift (Ala105ProfsTer11).</Attribute>
              <Citation>
                <ID Source="PubMed">22167769</ID>
              </Citation>
              <XRef DB="OMIM" ID="613795" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD3" />
          </GeneList>
          <Name>SMAD3, 1-BP DEL, 313G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 313G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603109.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LOEYS-DIETZ SYNDROME 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1759695" SubmissionDate="2018-11-27" DateLastUpdated="2019-04-17" DateCreated="2019-04-17">
        <ClinVarSubmissionID localKey="19" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000897883" DateUpdated="2019-04-17" DateCreated="2019-04-17" Type="SCV" Version="1" SubmitterName="Seelig Lab, University of Washington" OrgID="506798" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <CellLine>HEK 293T</CellLine>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NextSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <Description>HEK293T cells were plated on 10 cm cell culture dishes 24 hours before transfection (1 - 2 million per plate). At 60% to 80% confluency, cells were transfected with 14.5 micrograms of library mRNA using Lipofectamine MessengerMAX (Thermo Fisher Scientific) following the manufacturer's protocol. Plates were washed with 10 ml 1x DBPS and 10 ml media (DMEM with 10% FBS and 1% Penicillin-Streptomycin) after one hour of incubation. Cells were lysed 12 hours after transfection. After 12 hours of growth at 37 degrees C, cells were placed on ice and media was aspirated. Translating ribosomes were halted by adding 5 ml of wash buffer and were then placed at 37 degrees C for 5 minutes followed by aspiration on ice. Washed by adding 5 ml wash buffer and aspirating thoroughly. Added 300 microliters of ice-cold lysis buffer, scraped cells, broke up cell clumps by pipetting ~5 times, and then placed suspended cells into a pre-chilled microcentrifuge tube. Let sit for 10 minutes on ice and then triturated by passing through a 25-G needle 10 times. Spun at 16,000 x g for 5 minutes to pellet cell debris and nuclei. Saved supernatant and added 1.5 microliters of 1 U/microliter DNase I (final concentration of 0.005 U/microliter) and placed on ice for 30 minutes. Either stored at -80 degrees C or proceeded directly to polysome profiling.</Description>
              <MethodType>in vitro</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">Significant log2 change in mean ribosome load: 1.21</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <URL>https://www.biorxiv.org/content/10.1101/310375v1</URL>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <FunctionalConsequence Value="effect on translation">
            <XRef DB="Variation Ontology" ID="0399" URL="http://www.variationontology.org/cgi-bin/amivario/term-details.cgi?term=VariO:0399" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.10:g.67165001delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4797518</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1759695" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="49795" TraitType="Disease" MappingType="Name" MappingValue="LOEYS-DIETZ SYNDROME 3" MappingRef="Preferred">
        <MedGen CUI="C3151087" Name="Aneurysm-osteoarthritis syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

